PUBLISHER: The Business Research Company | PRODUCT CODE: 1946949
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946949
Peripheral nerve injury encompasses any damage or impairment affecting the peripheral nerves, which are the nerves situated outside the brain and spinal cord. These nerves play a vital role in transmitting signals between the central nervous system (CNS) and the rest of the body, facilitating sensation, movement, and motor coordination.
The primary product categories for addressing peripheral nerve injuries include nerve conduits, nerve protectors, nerve connectors, and nerve wraps. Nerve protectors are medical devices or materials utilized to shield and safeguard nerves from harm or injury during surgical procedures. Various types of injuries, such as traumatic, compression, and surgical injuries, are treated through diverse surgical interventions such as direct nerve repair, nerve grafting, and stem cell therapy. These interventions find application in a range of areas such as upper extremities and lower extremities, catering to diverse end-users including hospitals and clinics, rehabilitation centers, and home care settings.
Tariffs are influencing the peripheral nerve injuries market by increasing costs of imported biomaterials, collagen scaffolds, polymeric conduits, and precision surgical instruments. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported advanced nerve repair products, while Asia-Pacific faces higher production costs for export-oriented biomaterial devices. These tariffs are increasing treatment costs and procurement expenses. However, they are also driving local biomaterial manufacturing, regional innovation in nerve repair technologies, and greater investment in domestic regenerative medicine solutions.
The peripheral nerve injuries market research report is one of a series of new reports from The Business Research Company that provides peripheral nerve injuries market statistics, including peripheral nerve injuries industry global market size, regional shares, competitors with a peripheral nerve injuries market share, detailed peripheral nerve injuries market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral nerve injuries industry. This peripheral nerve injuries market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The peripheral nerve injuries market size has grown rapidly in recent years. It will grow from $4.41 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing incidence of traumatic injuries, growth in surgical nerve repair procedures, advancements in microsurgical techniques, rising awareness of nerve injury treatment options, improved post-surgical rehabilitation services.
The peripheral nerve injuries market size is expected to see rapid growth in the next few years. It will grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growing adoption of stem cell-assisted nerve repair, rising investments in regenerative medicine research, expansion of advanced biomaterial usage, increasing demand for minimally invasive nerve repair, growing focus on long-term functional recovery. Major trends in the forecast period include increasing use of bioabsorbable nerve repair products, rising adoption of advanced nerve conduits and wraps, growing integration of regenerative medicine approaches, expansion of microsurgical nerve repair techniques, enhanced focus on functional recovery outcomes.
The rising incidence of accidents is expected to drive the growth of the peripheral nerve injuries market in the coming years. This increase in accidents is influenced by factors such as urbanization leading to higher traffic volumes, lifestyle and environmental conditions, and distracted behaviors. Peripheral nerve injuries often require comprehensive treatment strategies to reduce their impact and support recovery. Investigational therapies, including stem cell therapy, growth factor administration, and gene therapy, show potential for promoting nerve regeneration and improving functional outcomes for patients injured in accidents. For example, in August 2025, according to the International Transport Forum, a France-based intergovernmental organization, Australia recorded 1,297 road deaths in 2024, representing a 4% increase compared to 2023. Therefore, the growing incidence of accidents is fueling the expansion of the peripheral nerve injuries market.
The rising adoption of minimally invasive surgeries is expected to drive the growth of the peripheral nerve injuries market in the coming years. Minimally invasive surgeries involve small incisions, specialized instruments, and advanced imaging techniques to reduce patient recovery time, pain, and the risk of complications. The growing use of these procedures is driven by factors such as shorter recovery periods, lower complication rates, and improved patient outcomes. Managing peripheral nerve injuries requires precise, targeted approaches to avoid damage to surrounding tissues, which has led to the development of advanced surgical tools, including robotic systems, endoscopic instruments, and precision-guided technologies. These innovations enable more accurate interventions with minimal incisions, reducing the risk of nerve injury and enhancing recovery. For example, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures rose by 7% in 2023, surpassing the overall growth rate of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger procedures, totaled 207,887 cases, marking a 2% increase from 2022. Therefore, the increasing adoption of minimally invasive surgeries is driving the expansion of the peripheral nerve injuries market.
Leading companies in the peripheral nerve injuries market are developing innovative solutions, such as resorbable soft-tissue barrier allografts, to enhance nerve protection and improve surgical healing outcomes. These allografts serve as temporary physical barriers that prevent adhesions and soft-tissue attachments during the critical early phase of nerve repair, offering advantages over traditional approaches like synthetic wraps or no coverage, which can result in scarring, tethering, or impaired nerve gliding. For example, in June 2024, Axogen Inc., a US-based biotechnology company, launched Avive+ Soft Tissue Matrix(TM), a resorbable, multi-layer amniotic membrane allograft designed to provide temporary protection and tissue separation during the early stages of peripheral nerve healing. Avive+ is composed of a multi-layer placental (amniotic) membrane processed in compliance with FDA HCT/P regulations (21 CFR Part 1271) and is intended to remain in place for up to 16 weeks. It offers robust handling, suturability, and strong barrier function while preserving the natural properties of the amniotic tissue. Its applications include acutely traumatized nerves, crushed (non-transected) injuries, and surgical settings where soft-tissue protection is essential.
Major companies operating in the peripheral nerve injuries market are Medtronic Plc, Stryker Corporation, Integra LifeSciences Holdings Corp., Bioventus LLC, MicroPort Scientific Corporation, AxoGen Inc., Bioness Inc., SPR Therapeutics Inc., NeuroMetrix Inc., Polyganics BV, Regenity Biosciences, Renerva LLC, Neuraptive Therapeutics Inc., Neuros Medical Inc., Synapse Biomedical Inc., Orthocell Ltd., NeuraLace Medical Inc., Epineuron LLC, Checkpoint Surgical Inc., Collagen Matrix Inc.
North America was the largest region in the peripheral nerve injuries market in 2025. The regions covered in the peripheral nerve injuries market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the peripheral nerve injuries market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The peripheral nerve injuries market consists of sales of nerve injury medications, gene therapies, and stem cell therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Peripheral Nerve Injuries Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses peripheral nerve injuries market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for peripheral nerve injuries ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripheral nerve injuries market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.